| RS2105447247 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Early-infantile DEE |
| RS2105447944 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105448260 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2105448524 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS2105449347 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105449751 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS2105449923 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105449932 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS2105455133 |
NFE2L2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2105458487 |
NFE2L2
|
Health Risk |
Likely pathogenic |
Lung cancer, Lung cancer |
| RS2105459482 |
NFE2L2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency, developmental delay |
| RS2105462218 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2105462303 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105462778 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105466704 |
WDPCP
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 15 |
| RS2105467271 |
LRP2
|
Health Risk |
Likely pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS2105475598 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105475874 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105475961 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS2105475986 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105476040 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105476084 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2105476313 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105476550 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2105476619 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105476794 |
SCN1A
|
Health Risk |
Likely pathogenic |
Sudden unexplained death in childhood, Sudden unexplained death in childhood |
| RS2105486615 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Migraine, familial hemiplegic |
| RS2105486716 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2105487145 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105500878 |
WDPCP
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 15 |
| RS2105507548 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105507958 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105508454 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2105508605 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105509347 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105509369 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS2105509458 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105509598 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105509616 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS2105509873 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105510219 |
SP9
|
Health Risk |
Pathogenic |
Abnormal caudate nucleus morphology, Epileptic encephalopathy |
| RS2105510265 |
SP9
|
Health Risk |
Pathogenic |
Autistic behavior, Intellectual disability |
| RS2105510286 |
SP9
|
Health Risk |
Pathogenic |
6 conditions, 6 conditions |
| RS2105510576 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105516384 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2105516399 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS2105520379 |
LCT
|
Health Risk |
Pathogenic |
— |
| RS2105531423 |
LCT
|
Health Risk |
Pathogenic |
— |
| RS2105537032 |
MBD5
|
Health Risk |
Pathogenic |
— |
| RS2105537748 |
LCT
|
Health Risk |
Pathogenic |
— |
| RS2105547148 |
SCN1A
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS2105547851 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105562669 |
LCT
|
Health Risk |
Pathogenic |
— |
| RS2105567922 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105569036 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS2105569222 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105569513 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105569536 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105569550 |
CERKL
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS2105569594 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105569724 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Early-infantile DEE |
| RS2105569996 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105570237 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105570349 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105570494 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2105571117 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2105571301 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105571316 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105571418 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2105571544 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105571577 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105579086 |
COL5A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2105581875 |
PDE11A
|
Health Risk |
Likely pathogenic |
Pigmented nodular adrenocortical disease, primary |
| RS2105591537 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105591567 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105591602 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105592343 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS2105592653 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105593011 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS2105593110 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105593894 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2105593982 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105594076 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS2105594483 |
NEUROD1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2105601199 |
NR4A2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism, Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism |
| RS2105602706 |
NR4A2
|
Health Risk |
Likely pathogenic |
— |
| RS2105604954 |
NR4A2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism, Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism |
| RS2105605019 |
NR4A2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2105605124 |
NR4A2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism, Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism |
| RS2105605264 |
NR4A2
|
Health Risk |
Pathogenic |
Parkinson disease, late-onset |
| RS2105608859 |
NR4A2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism, Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism |
| RS2105609699 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105609833 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2105610047 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105610084 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS2105610260 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2105610528 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2105610895 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105611998 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105612020 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |